Humana and Monogram Health, a value-based multispecialty provider of in-home care and benefit management services for patients living with kidney disease, have expanded their partnership to patients ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

In Europe alone, approximately 2 million people live with chronic inflammatory bowel diseases (IBD), and their incidence has ...

Employees in Hoboken, N.J., Charlotte, N.C. and San Bruno, Calif., are affected by potential layoffs or relocation.

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.